Insider transactions

EDGAR

IO Biotech, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-22.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

This issuer has insider filings in the store, but no transaction in this window or code group.

Latest reported holdings

What each reporting owner last said they hold, as of the date shown. A transaction not yet filed is not in it.

Latest reported holdings
Reporting ownerSecurityShares owned afterDirect or indirectSource
Ahmad Qasim Iftikhar Officer: Chief Medical OfficerStock Option (Right to Buy) Derivative security · underlying Common Stock215,000D As of 2025-04-02 Open filing 4
Ahmad Qasim Iftikhar Officer: Chief Medical OfficerCommon Stock 31,350D As of 2024-12-23 Open filing 4
Burkavage Brian Officer: Chief Accounting OfficerStock Option (Right to Buy) Derivative security · underlying Common Stock65,000D As of 2025-04-02 Open filing 4
Collins Helen Louise DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock35,144D As of 2025-06-05 Open filing 4
Elling Christian E DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock35,144D As of 2025-06-05 Open filing 4
Glaub Kathleen Sereda DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock35,144D As of 2025-06-05 Open filing 4
Hirth Peter DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock35,144D As of 2025-06-05 Open filing 4
Hunter Heidi DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock35,144D As of 2025-06-05 Open filing 4
Hunter Heidi DirectorCommon Stock 15,000D As of 2025-05-30 Open filing 4
Smith David V DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock35,144D As of 2025-06-05 Open filing 4
Smith Devin Whittemore Officer: General CounselStock Option (Right to Buy) Derivative security · underlying Common Stock140,000D As of 2025-04-02 Open filing 4
Smith Devin Whittemore Officer: General CounselCommon Stock 16,938D As of 2024-12-23 Open filing 4
Sullivan Amy Officer: Chief Financial OfficerStock Option (Right to Buy) Derivative security · underlying Common Stock215,000D As of 2025-04-02 Open filing 4
Sullivan Amy Officer: Chief Financial OfficerCommon Stock 84,632D As of 2024-12-23 Open filing 4
Zocca Mai-Britt Director · Officer: Chief Executive OfficerStock Option (Right to Buy) Derivative security · underlying Common Stock580,000D As of 2025-04-02 Open filing 4
Zocca Mai-Britt Director · Officer: Chief Executive OfficerCommon Stock 26,580I Zocca Consulting ApSAs of 2024-12-23 Open filing 4
Zocca Mai-Britt Director · Officer: Chief Executive OfficerCommon Stock 49,891D As of 2024-12-23 Open filing 4

Joint filers each report the same shares, so rows are not added together.

Institutional holders (Form 13F)

No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.

Institutional ownership reported on Form 13F

No percent is shown: the cover-page share count is not available for this company.

  • The lower figure counts positions a manager reports as its own with sole discretion. The upper figure counts every plain-share position and can count a share twice.
  • Neither includes holders that do not file Form 13F, or managers below the filing threshold.
Quarter-by-quarter 13F holders
QuarterManagers holdingShares, at leastShares, at mostFilings read
2026-09-30 0008,935
2026-06-30 0009,178
2026-03-31 121,971,6753,391,5819,173
2025-12-31 225,196,8617,848,1839,222
2025-09-30 215,576,4449,895,8758,469
2025-06-30 2710,272,24018,182,7078,516
2025-03-31 2310,572,00419,111,6178,518
2024-12-31 2810,765,58819,737,8628,580

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read from their tags. Earlier schedules are free text: they are read only when every cover page states a share count and a percent, and the rest are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
HBM Healthcare Investments (Cayman) Ltd. Common Stock, par value $0.001 per share3.32,433,943.0004/02/2026 Filed 2026-04-06SCHEDULE 13G/AAmendment 5Open filing 0001104659-26-039923 Dispute this row
Lundbeckfond Invest A/S Common Stock, par value $0.001 per share27.421,851,920.0003/31/2026 Filed 2026-06-02SCHEDULE 13D/AAmendment 2Open filing 0001591046-26-000008 Dispute this row
Chernett Jorey Common Stock, $0.001 Par Value Per Share00.0003/31/2026 Filed 2026-05-20SCHEDULE 13G/AAmendment 2Open filing 0000921895-26-001459 Dispute this row
Point72 Asset Management, L.P. Common Stock, par value $0.001 per share00.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-003515 Dispute this row
Point72 Capital Advisors, Inc. Common Stock, par value $0.001 per share00.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-003515 Dispute this row
Steven A. Cohen Common Stock, par value $0.001 per share00.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-003515 Dispute this row
Point72 Asset Management, L.P. Common Stock, par value $0.001 per share5.64,027,112.0002/05/2026 Filed 2026-02-06SCHEDULE 13GOpen filing 0000902664-26-000777 Dispute this row
Point72 Capital Advisors, Inc. Common Stock, par value $0.001 per share5.64,027,112.0002/05/2026 Filed 2026-02-06SCHEDULE 13GOpen filing 0000902664-26-000777 Dispute this row
Steven A. Cohen Common Stock, par value $0.001 per share5.64,027,112.0002/05/2026 Filed 2026-02-06SCHEDULE 13GOpen filing 0000902664-26-000777 Dispute this row
Novo Holdings A/S Common Stock, par value $0.001 per share3.32,469,135.0001/21/2026 Filed 2026-01-23SCHEDULE 13D/AAmendment 8Open filing 0001388325-26-000003 Dispute this row
Chernett Jorey Common6.34,543,532.0012/31/2025 Filed 2026-02-13SCHEDULE 13G/AAmendment 1Open filing 0002042077-26-000015 Dispute this row
Chernett Jorey Common5.33,477,162.0010/30/2025 Filed 2025-11-05SCHEDULE 13GOpen filing 0002042077-25-000006 Dispute this row
Vivo Capital IX, LLC Common stock, par value $0.001 per share00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001213900-25-111138 Dispute this row
Vivo Capital Fund IX, L.P. Common stock, par value $0.001 per share00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001213900-25-111138 Dispute this row
Vivo Opportunity, LLC Common stock, par value $0.001 per share4.63,157,894.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001213900-25-111138 Dispute this row
Vivo Opportunity Fund Holdings, L.P. Common stock, par value $0.001 per share4.63,157,894.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001213900-25-111138 Dispute this row
Novo Holdings A/S Common Stock, par value $0.001 per share7.34,981,588.0008/11/2025 Filed 2025-08-19SCHEDULE 13D/AAmendment 7Open filing 0001415889-25-022324 Dispute this row
BANK OF AMERICA CORPORATION Common Stock2.81,844,185— Filed 2024-02-13SC 13G/AAmendment 01Read from the cover page textOpen filing 0000070858-24-000110 Dispute this row
Stonepine Capital Management, LLC Common Stock, $0.001 par value per share5.43,641,345— Filed 2024-02-13SC 13G/AAmendment 1Read from the cover page textOpen filing 0000935836-24-000138 Dispute this row
Stonepine Capital, L.P. Common Stock, $0.001 par value per share5.43,641,345— Filed 2024-02-13SC 13G/AAmendment 1Read from the cover page textOpen filing 0000935836-24-000138 Dispute this row
Jon M. Plexico Common Stock, $0.001 par value per share5.43,641,345— Filed 2024-02-13SC 13G/AAmendment 1Read from the cover page textOpen filing 0000935836-24-000138 Dispute this row
Timothy P. Lynch Common Stock, $0.001 par value per share5.43,641,345— Filed 2024-02-13SC 13G/AAmendment 1Read from the cover page textOpen filing 0000935836-24-000138 Dispute this row
HBM Healthcare Investments (Cayman) Ltd. Common Stock, par value $0.001 per share6.03,944,492— Filed 2024-02-13SC 13G/AAmendment 3Read from the cover page textOpen filing 0001104659-24-019876 Dispute this row
Samsara BioCapital, L.P. Common Stock, $0.001 par value per share5.53,640,015— Filed 2023-12-18SC 13GRead from the cover page textOpen filing 0001104659-23-126952 Dispute this row
Samsara BioCapital GP, LLC Common Stock, $0.001 par value per share5.53,640,015— Filed 2023-12-18SC 13GRead from the cover page textOpen filing 0001104659-23-126952 Dispute this row
Dr. Srinivas Akkaraju Common Stock, $0.001 par value per share5.53,640,015— Filed 2023-12-18SC 13GRead from the cover page textOpen filing 0001104659-23-126952 Dispute this row
Kurma Partners Common Stock, $0.001 par value per share17.1812,253,230— Filed 2023-09-07SC 13GRead from the cover page textOpen filing 0001140361-23-043145 Dispute this row
Stonepine Capital Management, LLC Common Stock, $0.001 par value per share5.83,950,616— Filed 2023-08-16SC 13GRead from the cover page textOpen filing 0000935836-23-000590 Dispute this row
Stonepine Capital, L.P. Common Stock, $0.001 par value per share5.83,950,616— Filed 2023-08-16SC 13GRead from the cover page textOpen filing 0000935836-23-000590 Dispute this row
Jon M. Plexico Common Stock, $0.001 par value per share5.83,950,616— Filed 2023-08-16SC 13GRead from the cover page textOpen filing 0000935836-23-000590 Dispute this row
Timothy P. Lynch Common Stock, $0.001 par value per share5.83,950,616— Filed 2023-08-16SC 13GRead from the cover page textOpen filing 0000935836-23-000590 Dispute this row
HBM Healthcare Investments (Cayman) Ltd. Common Stock, par value $0.001 per share8.195,523,439— Filed 2023-08-15SC 13G/AAmendment 2Read from the cover page textOpen filing 0001140361-23-039880 Dispute this row
Lundbeckfond Invest A/S Common Stock, par value $0.001 per share29.621,851,920— Filed 2023-08-14SC 13D/AAmendment 1Read from the cover page textOpen filing 0001140361-23-039639 Dispute this row
HBM Healthcare Investments (Cayman) Ltd. Common Stock, par value $0.001 per share6.13,999,431— Filed 2023-08-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0001140361-23-039640 Dispute this row
Novo Holdings A/S Common Stock, par value $0.001 per share12.08,216,202— Filed 2023-08-11SC 13D/AAmendment 3Read from the cover page textOpen filing 0001193125-23-210822 Dispute this row
BANK OF AMERICA CORPORATION Common Stock6.41,854,185— Filed 2023-02-14SC 13GRead from the cover page textOpen filing 0000070858-23-000065 Dispute this row
RA Capital Management, L.P. Common Stock, par value $0.001 per share3.91,127,260— Filed 2023-02-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0001104659-23-021806 Dispute this row
Peter Kolchinsky Common Stock, par value $0.001 per share3.91,127,260— Filed 2023-02-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0001104659-23-021806 Dispute this row
Rajeev Shah Common Stock, par value $0.001 per share3.91,127,260— Filed 2023-02-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0001104659-23-021806 Dispute this row
RA Capital Healthcare Fund, L.P. Common Stock, par value $0.001 per share3.4994,265— Filed 2023-02-14SC 13G/AAmendment 1Read from the cover page textOpen filing 0001104659-23-021806 Dispute this row
Novo Holdings A/S Common Stock, par value $0.001 per share11.43,277,932— Filed 2022-09-30SC 13D/AAmendment 2Read from the cover page textOpen filing 0001193125-22-255654 Dispute this row
Novo Holdings A/S Common Stock, par value $0.0001 per share11.33,277,932— Filed 2022-05-26SC 13D/AAmendment 1Read from the cover page textOpen filing 0001193125-22-160579 Dispute this row
HBM Healthcare Investments (Cayman) Ltd. Common Stock, par value $0.001 per share8.42,420,484— Filed 2022-02-11SC 13GRead from the cover page textOpen filing 0001104659-22-020452 Dispute this row
Avoro Capital Advisors LLC Common Stock, par value $0.001 per share7.12,055,883— Filed 2022-02-11SC 13GRead from the cover page textOpen filing 0000902664-22-001522 Dispute this row
Behzad Aghazadeh Common Stock, par value $0.001 per share7.12,055,883— Filed 2022-02-11SC 13GRead from the cover page textOpen filing 0000902664-22-001522 Dispute this row
RA Capital Management, L.P. Common Stock, par value $0.001 per share6.41,857,755— Filed 2021-11-19SC 13GRead from the cover page textOpen filing 0001104659-21-141912 Dispute this row
Peter Kolchinsky Common Stock, par value $0.001 per share6.41,857,755— Filed 2021-11-19SC 13GRead from the cover page textOpen filing 0001104659-21-141912 Dispute this row
Rajeev Shah Common Stock, par value $0.001 per share6.41,857,755— Filed 2021-11-19SC 13GRead from the cover page textOpen filing 0001104659-21-141912 Dispute this row
RA Capital Healthcare Fund, L.P. Common Stock, par value $0.001 per share5.71,641,972— Filed 2021-11-19SC 13GRead from the cover page textOpen filing 0001104659-21-141912 Dispute this row
Lundbeckfond Invest A/S Common Stock, par value $0.001 per share21.86,049,452— Filed 2021-11-19SC 13DRead from the cover page textOpen filing 0001140361-21-038709 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

3,092,627 filings read, dated 1980-01-02 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015246,723
2016246,472
2017244,814
2018245,575
2019238,619
2020249,093
2021274,850
2022257,922
2023253,676
2024261,106
2025235,525
2026263,830

Filings made before the SEC required XML are listed, not extracted.

Back to IO Biotech, Inc.